HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marked regression of pulmonary rheumatoid nodules under etanercept therapy.

AuthorsGaelle Derot, Andre Marini-Portugal, Bernard Maitre, Pascal Claudepierre
JournalThe Journal of rheumatology (J Rheumatol) Vol. 36 Issue 2 Pg. 437-9 (Feb 2009) ISSN: 0315-162X [Print] Canada
PMID19208569 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antirheumatic Agents
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Etanercept
  • Methotrexate
Topics
  • Antirheumatic Agents (administration & dosage)
  • Arthritis, Rheumatoid (complications, drug therapy)
  • Disease Progression
  • Drug Administration Schedule
  • Etanercept
  • Female
  • Humans
  • Immunoglobulin G (administration & dosage)
  • Lung (diagnostic imaging, drug effects, pathology)
  • Methotrexate (therapeutic use)
  • Middle Aged
  • Multiple Pulmonary Nodules (diagnostic imaging, drug therapy, immunology)
  • Receptors, Tumor Necrosis Factor (administration & dosage)
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha (antagonists & inhibitors, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: